East Coast Genetics, LLC is a large-scale hemp genetics company dedicated to providing farmers with superior quality, high CBD strains. Founded in 2016, ECG obtained the broad licensing rights for the trademarked strain, Cherry Wine. Our genetics team has since isolated the top-performing Cherry Wine phenotypes. Our library of strains has recently expanded beyond Cherry Wine. Sweetened and Franklin Otto, BaOx, and T1 have also been added. 

 ECG and our network of distributors in North Carolina and Virginia pride ourselves on providing organically grown, reliable strains guaranteed to ensure the grower the highest CBD yields with natural resistance to pests and mold.  ECG offers multiple programs to fit your farms needs.  ECG is partnered with Hempleton Investment Group, providing plant to buyer programs for a limited amount of farmers.  These programs include built in consulting throughout the grow season.  

  Each strain undergoes variety trials at both our indoor facility and outdoors at The NC Hemp Farm Research & Innovation Campuses. All strains are evaluated on plant structure, cannabinoid content, flowering cycles, and pest resistance. We believe that providing researchbacked genetics sets us apart from the competition.